ACTO will advance PharmaForce and CxZone to improve training, knowledge access and customer engagement in life sciences, enabling safe, scalable AI and faster time-to-competency.
ACTO Technologies Inc.
3 enregistrements totalisant 993,747.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $576,068 | 2 enregistrements |
| Innovation, Sciences et Développement économique Canada | $417,679 | 1 enregistrement |
Enregistrements
Acto Technologies Inc.
$417,679.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
AI Compute Access Fund
EF 2025-2026
Canada
ACTO Technologies Inc.
$376,068.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
ACTO Technologies Inc.
$200,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada
Leveraging content on ACTO's Omnichannel platform, LAICA's suite of AI solutions will deliver a series of technologies: 1. Enterprise Search Solution; 2. Recommendation System; and 3. Targeted Insigh...